I’d be more likely to think 1H 2022 at a SP of 40-50c after raising enough to get 5-6 drugs thru the clinic. MCAP north of a billion given the relative chance of success being about 55% for drug 1 (assuming all is going well at that time.) 3years till a billion earnings from RP drug at that stage and the discount relevant to the mcap expectations of say 5-10 B could get the SP much higher than that too.
Ann: PYC Expands US Executive Leadership Team, page-4
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.010(5.26%) |
Mkt cap ! $933.2M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 20.0¢ | 18.8¢ | $963.9K | 4.978M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2692 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 445208 | 3 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| PYC (ASX) Chart |